Am. J. Respir. Cell Mol. Biol., Vol 13, No. 6, Dec 1995, 738-747.
Early identification of interleukin-16 (lymphocyte chemoattractant factor) and macrophage inflammatory protein 1 alpha (MIP1 alpha) in bronchoalveolar lavage fluid of antigen-challenged asthmatics
WW Cruikshank, A Long, RE Tarpy, H Kornfeld, MP Carroll, L Teran, ST Holgate and DM Center
Pulmonary Center, Boston University School of Medicine, Massachusetts, USA.
Accumulation of CD4+ interleukin (IL)-2R+ lymphocytes in the airways of
asthmatics is generally attributed to the presence of chemoattractant
cytokines. The precise mechanism for the initiation of the earliest CD4+
lymphocyte infiltration and activation is unknown. In this study, we
describe for the first time the presence of lymphocyte chemoattractant
activity in the bronchoalveolar lavage (BAL) fluid obtained from asthmatics
6 h after antigen challenge. The majority of the chemoattractant activity
at this early time point is represented by IL-16 (lymphocyte
chemoattractant factor), a CD4+ cell-specific chemoattractant and growth
factor. In addition to IL-16, macrophage inflammatory protein 1 alpha (MIP1
alpha) chemotactic bioactivity was detected in significant levels. While
IL-16, MIP1 alpha, and IL-8 were all identified by enzyme-linked
immunosorbent assay, the great majority of the lymphocyte chemoattractant
activity in the BAL fluid after antigen challenge is attributable to IL-16
and MIP1 alpha. There were no detectable levels of IL-16 nor MIP1 alpha in
BAL fluid of antigen- challenged normal subjects nor atopic nonasthmatics
nor in saline- challenged lobes from the asthmatics. The identification of
multiple lymphocyte chemoattractants early after antigen challenge suggests
a complex cellular, as well as chemoattractant cytokine, profile in
initiating the CD4+ T cell-mediated inflammatory process that is specific
for the atopic asthmatic phenotype.
This article has been cited by other articles:

|
 |

|
 |
 
C. McFadden, R. Morgan, S. Rahangdale, D. Green, H. Yamasaki, D. Center, and W. Cruikshank
Preferential Migration of T Regulatory Cells Induced by IL-16
J. Immunol.,
November 15, 2007;
179(10):
6439 - 6445.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. G. Gianoukakis, R. S. Douglas, C. S. King, W. W. Cruikshank, and T. J. Smith
Immunoglobulin G from Patients with Graves' Disease Induces Interleukin-16 and RANTES Expression in Cultured Human Thyrocytes: A Putative Mechanism for T-Cell Infiltration of the Thyroid in Autoimmune Disease
Endocrinology,
April 1, 2006;
147(4):
1941 - 1949.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Rahangdale, R. Morgan, C. Heijens, T. C. Ryan, H. Yamasaki, E. Bentley, E. Sullivan, D. M. Center, and W. W. Cruikshank
Chemokine Receptor CXCR3 Desensitization by IL-16/CD4 Signaling Is Dependent on CCR5 and Intact Membrane Cholesterol
J. Immunol.,
February 15, 2006;
176(4):
2337 - 2345.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Elssner, A. I. Doseff, M. Duncan, M. Kotur, and M. D. Wewers
IL-16 Is Constitutively Present in Peripheral Blood Monocytes and Spontaneously Released During Apoptosis
J. Immunol.,
June 15, 2004;
172(12):
7721 - 7725.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Lynch, C. A. W. Heijens, N. F. Horst, D. M. Center, and W. W. Cruikshank
Cutting Edge: IL-16/CD4 Preferentially Induces Th1 Cell Migration: Requirement of CCR5
J. Immunol.,
November 15, 2003;
171(10):
4965 - 4968.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. G. Gianoukakis, L. J. Martino, N. Horst, W. W. Cruikshank, and T. J. Smith
Cytokine-Induced Lymphocyte Chemoattraction from Cultured Human Thyrocytes: Evidence for Interleukin-16 and Regulated upon Activation, Normal T Cell Expressed, and Secreted Expression
Endocrinology,
July 1, 2003;
144(7):
2856 - 2864.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. F. Little, E. Lynch, G. Fine, D. M. Center, and W. W. Cruikshank
Tumor Necrosis Factor-{alpha}-Induced Synthesis of Interleukin-16 in Airway Epithelial Cells: Priming for Serotonin Stimulation
Am. J. Respir. Cell Mol. Biol.,
March 1, 2003;
28(3):
354 - 362.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Gantner, K. Sakai, M. W. Tusche, W. W. Cruikshank, D. M. Center, and K. B. Bacon
Histamine H4 and H2 Receptors Control Histamine-Induced Interleukin-16 Release from Human CD8+ T Cells
J. Pharmacol. Exp. Ther.,
October 1, 2002;
303(1):
300 - 307.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Melis, L. Siena, E. Pace, M. Gjomarkaj, M. Profita, A. Pirazzoli, M. Todaro, G. Stassi, G. Bonsignore, and A.M. Vignola
Fluticasone induces apoptosis in peripheral T-lymphocytes: a comparison between asthmatic and normal subjects
Eur. Respir. J.,
February 1, 2002;
19(2):
257 - 266.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Reich, A. Heine, S. Hugo, V. Blaschke, P. Middel, A. Kaser, H. Tilg, S. Blaschke, C. Gutgesell, and C. Neumann
Engagement of the Fc{epsilon}RI Stimulates the Production of IL-16 in Langerhans Cell-Like Dendritic Cells
J. Immunol.,
December 1, 2001;
167(11):
6321 - 6329.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. F. Little, W. W. Cruikshank, and D. M. Center
IL-9 Stimulates Release of Chemotactic Factors from Human Bronchial Epithelial Cells
Am. J. Respir. Cell Mol. Biol.,
September 1, 2001;
25(3):
347 - 352.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F. Kramer, B. Mack, and G. Rasp
Immunohistological Expression of Interleukin 16 in Human Tonsils
Arch Otolaryngol Head Neck Surg,
September 1, 2001;
127(9):
1120 - 1125.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Cheng, T. Ueda, F. Eda, M. Arima, N. Yoshida, and T. Fukuda
A549 Cells Can Express Interleukin-16 and Stimulate Eosinophil Chemotaxis
Am. J. Respir. Cell Mol. Biol.,
August 1, 2001;
25(2):
212 - 218.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. KRUG, W. W. CRUIKSHANK, T. TSCHERNIG, V. J. ERPENBECK, K. BALKE, J. M. HOHLFELD, D. M. CENTER, and H. FABEL
Interleukin 16 and T-cell Chemoattractant Activity in Bronchoalveolar Lavage 24 Hours after Allergen Challenge in Asthma
Am. J. Respir. Crit. Care Med.,
July 1, 2000;
162(1):
105 - 111.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. BOUSQUET, P. K. JEFFERY, W. W. BUSSE, M. JOHNSON, and A. M. VIGNOLA
Asthma . From Bronchoconstriction to Airways Inflammation and Remodeling
Am. J. Respir. Crit. Care Med.,
May 1, 2000;
161(5):
1720 - 1745.
[Full Text]
|
 |
|

|
 |

|
 |
 
T. Yoshimoto, C.-R. Wang, T. Yoneto, A. Matsuzawa, W. W. Cruikshank, and H. Nariuchi
Role of IL-16 in delayed-type hypersensitivity reaction
Blood,
May 1, 2000;
95(9):
2869 - 2874.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Lee, M. E. Brummet, S. Shahabuddin, T. G. Woodworth, S. N. Georas, K. M. Leiferman, S. C. Gilman, C. Stellato, R. P. Gladue, R. P. Schleimer, et al.
Cutaneous Injection of Human Subjects with Macrophage Inflammatory Protein-1{alpha} Induces Significant Recruitment of Neutrophils and Monocytes
J. Immunol.,
March 15, 2000;
164(6):
3392 - 3401.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Hidi, V. Riches, M. Al-Ali, W. W. Cruikshank, D. M. Center, S. T. Holgate, and R. Djukanovic
Role of B7-CD28/CTLA-4 Costimulation and NF-{kappa}B in Allergen-Induced T Cell Chemotaxis by IL-16 and RANTES
J. Immunol.,
January 1, 2000;
164(1):
412 - 418.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Arima, J. Plitt, C. Stellato, C. Bickel, S. Motojima, S. Makino, T. Fukuda, and R. P. Schleimer
Expression of Interleukin-16 by Human Epithelial Cells . Inhibition by Dexamethasone
Am. J. Respir. Cell Mol. Biol.,
December 1, 1999;
21(6):
684 - 692.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. Casale
Immunobiology of Asthma and Rhinitis . Pathogenic Factors and Therapeutic Options
Am. J. Respir. Crit. Care Med.,
November 1, 1999;
160(5):
1778 - 1787.
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Laan, I. Qvarfordt, G. C Riise, B. A Andersson, S. Larsson, and A. Lindén
Increased levels of interleukin-16 in the airways of tobacco smokers: relationship with peripheral blood T lymphocytes
Thorax,
October 1, 1999;
54(10):
911 - 916.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K F Chung and P J Barnes
Cytokines in asthma
Thorax,
September 1, 1999;
54(9):
825 - 857.
[Full Text]
|
 |
|

|
 |

|
 |
 
J. Nicoll, W. W. Cruikshank, W. Brazer, Y. Liu, D. M. Center, and H. Kornfeld
Identification of Domains in IL-16 Critical for Biological Activity
J. Immunol.,
August 15, 1999;
163(4):
1827 - 1832.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. PACE, M. GJOMARKAJ, M. MELIS, M. PROFITA, M. SPATAFORA, A. M. VIGNOLA, G. BONSIGNORE, and C. H. MODY
Interleukin-8 Induces Lymphocyte Chemotaxis into the Pleural Space . Role of Pleural Macrophages
Am. J. Respir. Crit. Care Med.,
May 1, 1999;
159(5):
1592 - 1599.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Sabroe, A. Hartnell, L. A. Jopling, S. Bel, P. D. Ponath, J. E. Pease, P. D. Collins, and T. J. Williams
Differential Regulation of Eosinophil Chemokine Signaling Via CCR3 and Non-CCR3 Pathways
J. Immunol.,
March 1, 1999;
162(5):
2946 - 2955.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Barnes, K. F. Chung, and C. P. Page
Inflammatory Mediators of Asthma: An Update
Pharmacol. Rev.,
December 1, 1998;
50(4):
515 - 596.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. L. Chupp, E. A. Wright, D. Wu, M. Vallen-Mashikian, W. W. Cruikshank, D. M. Center, H. Kornfeld, and J. S. Berman
Tissue and T Cell Distribution of Precursor and Mature IL-16
J. Immunol.,
September 15, 1998;
161(6):
3114 - 3119.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Keane, J. Nicoll, S. Kim, D. M. H. Wu, W. W. Cruikshank, W. Brazer, B. Natke, Y. Zhang, D. M. Center, and H. Kornfeld
Conservation of Structure and Function Between Human and Murine IL-16
J. Immunol.,
June 15, 1998;
160(12):
5945 - 5954.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Hessel, W. W. Cruikshank, I. Van Ark, J. J. De Bie, B. Van Esch, G. Hofman, F. P. Nijkamp, D. M. Center, and A. J. M. Van Oosterhout
Involvement of IL-16 in the Induction of Airway Hyper-Responsiveness and Up-Regulation of IgE in a Murine Model of Allergic Asthma
J. Immunol.,
March 15, 1998;
160(6):
2998 - 3005.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. T. HOLGATE, K. S. BODEY, A. JANEZIC, A. J. FREW, A. P. KAPLAN, and L. M. TERAN
Release of RANTES, MIP-1alpha , and MCP-1 into Asthmatic Airways Following Endobronchial Allergen Challenge
Am. J. Respir. Crit. Care Med.,
November 1, 1997;
156(5):
1377 - 1383.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. J. Thomassen, L. T. Buhrow, M. J. Connors, F. Kaneko, S. C. Erzurum, and M. S. Kavuru
Nitric Oxide Inhibits Inflammatory Cytokine Production by Human Alveolar Macrophages
Am. J. Respir. Cell Mol. Biol.,
September 1, 1997;
17(3):
279 - 283.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Laberge, P. Ernst, O. Ghaffar, W. W. Cruikshank, H. Kornfeld, D. M. Center, and Q. Hamid
Increased Expression of Interleukin-16 in Bronchial Mucosa of Subjects with Atopic Asthma
Am. J. Respir. Cell Mol. Biol.,
August 1, 1997;
17(2):
193 - 202.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1995 American Thoracic Society.
|
|
|